IMA Q4 2020 Earnings — ImageneBio Inc Revenue & Financial Results | Market Cap Arena

IMAImageneBio Inc

$69M

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$65,000-97.7% YoY

Gross Profit

-$23M-35903.1% margin

Operating Income

-$26M-40081.5% margin

Net Income

-$26M-40078.5% margin

EPS (Diluted)

$-1.86

QoQ Revenue Growth

-97.7%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$650,000

Balance Sheet

Total Assets

$168M

Total Liabilities

$269M

Stockholders' Equity

-$101M

Cash & Equivalents

$162M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$65,000	$3M	-97.7%
Gross Profit	-$23M	-$3M	-638.5%
Operating Income	-$26M	-$5M	-378.7%
Net Income	-$26M	-$5M	-410.0%